Proliferative activity of colonic mucosa at different distances from primary adenocarcinoma as determined by the presence of statin
- 1 September 1992
- journal article
- Published by Wolters Kluwer Health in Diseases of the Colon & Rectum
- Vol. 35 (9) , 879-883
- https://doi.org/10.1007/bf02047877
Abstract
The field change is one hypothesis concerning the development of colorectal carcinoma. Removal of a carcinoma without its entire surrounding altered mucosa may result in the development of a recurrence. S44, a monoclonal antibody directed against statin, a nuclear protein expressed in nonproliferating cells in either a quiescent or senescent state, was used to determine the rate of cell growth in colorectal mucosa at different distances from carcinomas. The specimens of 18 patients undergoing resection of a colorectal carcinoma were immediately opened after operation, and strips of mucosa were taken at distances of 1 cm, 5 cm, and 10 cm from the carcinoma. For each location, 10 longitudinally oriented crypts were evaluated for statin-positive cells identified by the presence of a dark brown peroxidase-conjugated antibody reaction product. The average percentage of statin-positive cells per crypt was significantly lower at a 1-cm distance from the carcinoma compared with the mucosa located 5 and 10 cm from the carcinoma (20.89±4.33 at 1 cm, 32.41±5.27 at 5 cm, and 34.23±6.45 at 10 cm). None of the calculated parameters showed any significant difference between the 5-cm and 10-cm locations. The fact that the proliferation rate of the mucosal cells returns to the normal level at 5 cm from the margin of the carcinoma suggests that cells located within this distance still retain proliferative potential even though they are morphologically indistinguishable from their normal counterparts. We conclude that failure to remove this transitional, potentially proliferative mucosa may result in subsequent development of anastomotic or perianastomotic recurrences.Keywords
This publication has 24 references indexed in Scilit:
- Statin, a nonproliferation‐specific protein, is associated with the nuclear envelope and is heterogeneously distributed in cells leaving quiescent stateJournal of Cellular Physiology, 1989
- A rat liver 57-kDa protein is identified to share antigenic determinants with statin, a marker for nonproliferating cellsExperimental Cell Research, 1989
- Influence of sialomucin at the resection margin on local tumour recurrence and survival of patients with colorectal cancer: A multivariate analysisBritish Journal of Surgery, 1987
- Application of a unique monoclonal antibody as a marker for nonproliferating subpopulations of cells of some tissue.Journal of Histochemistry & Cytochemistry, 1985
- The sialomucin content of colonic resection marginsDiseases of the Colon & Rectum, 1985
- A 57,000-mol-wt protein uniquely present in nonproliferating cells and senescent human fibroblasts.The Journal of cell biology, 1985
- Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.Journal of Histochemistry & Cytochemistry, 1981
- Transitional mucosa and survival in human colorectal cancerCancer, 1980
- The value of a study of the mucosubstances in rectal biopsies from patients with carcinoma of the rectum and lower sigmoid in the diagnosis of premalignant mucosaJournal of Clinical Pathology, 1972
- Value of histochemical reactions for mucosubstances in the diagnosis of certain pathological conditions of the colon and rectum.Gut, 1969